Concepedia

Publication | Open Access

Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer

DOIFull Paper Access

51

Citations

22

References

2014

Year

Hyman B. Muss, Javier Cortés, Linda T. Vahdat, Fátima Cardoso, Chris Twelves, J. Wanders, Corina E. Dutcus, Jay Yang, Seth Seegobin, Joyce O’Shaughnessy
The Oncologist

Abstract

Eribulin monotherapy in these selected older patients with good baseline performance status led to OS, PFS, ORR, CBR, and tolerability similar to those of younger patients with metastatic breast cancer. The benefits and risks of eribulin appear to be similar across age groups.

References

YearCitations

Page 1